APO Research
Talk to an analyst

APO RESEARCH · REPORT

Activin Receptor Type 1

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Activin Receptor Type 1 Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchActivin Receptor Type 1 Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Activin Receptor Type 1 Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Activin Receptor Type 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Activin Receptor Type 1 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Activin Receptor Type 1 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Activin Receptor Type 1 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Activin Receptor Type 1 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Activin Receptor Type 1 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Activin Receptor Type 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Activin Receptor Type 1 include Tolero Pharmaceuticals Inc, Oncodesign SA, La Jolla Pharmaceutical Company, Daiichi Sankyo Company Ltd and Blueprint Medicines Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Activin Receptor Type 1 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Activin Receptor Type 1 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Activin Receptor Type 1 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Activin Receptor Type 1.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Activin Receptor Type 1 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Activin Receptor Type 1 Market by Company

Tolero Pharmaceuticals Inc

Oncodesign SA

La Jolla Pharmaceutical Company

Daiichi Sankyo Company Ltd

Blueprint Medicines Corp

Activin Receptor Type 1 Segment by Type

LJPC-6417

Dipyridamole

TP-0184

Others

Activin Receptor Type 1 Segment by Application

Alport Syndrome

Kidney Fibrosis

Chronic Kidney Disease

Obesity

Others

Activin Receptor Type 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Activin Receptor Type 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Activin Receptor Type 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Activin Receptor Type 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Activin Receptor Type 1 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Activin Receptor Type 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of LJPC-6417 Table 2. Major Company of Dipyridamole Table 3. Major Company of TP-0184 Table 4. Major Company of Others Table 5. Global Activin Receptor Type 1 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Activin Receptor Type 1 Sales by Type (2021-2026) & (W Units) Table 7. Global Activin Receptor Type 1 Sales Market Share in Volume by Type (2021-2026) Table 8. Global Activin Receptor Type 1 Sales by Type (2021-2026) & (US$ Million) Table 9. Global Activin Receptor Type 1 Sales Market Share in Value by Type (2021-2026) Table 10. Global Activin Receptor Type 1 Price by Type (2021-2026) & (US$/Unit) Table 11. Global Activin Receptor Type 1 Sales by Type (2027-2032) & (W Units) Table 12. Global Activin Receptor Type 1 Sales Market Share in Volume by Type (2027-2032) Table 13. Global Activin Receptor Type 1 Sales by Type (2027-2032) & (US$ Million) Table 14. Global Activin Receptor Type 1 Sales Market Share in Value by Type (2027-2032) Table 15. Global Activin Receptor Type 1 Price by Type (2027-2032) & (US$/Unit) Table 16. North America Activin Receptor Type 1 Sales by Type (2021-2026) & (W Units) Table 17. North America Activin Receptor Type 1 Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Activin Receptor Type 1 Sales by Type (2021-2026) & (W Units) Table 19. Europe Activin Receptor Type 1 Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Activin Receptor Type 1 Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Activin Receptor Type 1 Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Activin Receptor Type 1 Sales by Type (2021-2026) & (W Units) Table 23. Latin America Activin Receptor Type 1 Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Activin Receptor Type 1 Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Activin Receptor Type 1 Sales by Type (2021-2026) & (US$ Million) Table 26. Activin Receptor Type 1 Industry Trends Table 27. Activin Receptor Type 1 Industry Drivers Table 28. Activin Receptor Type 1 Industry Opportunities and Challenges Table 29. Activin Receptor Type 1 Industry Restraints Table 30. Global Activin Receptor Type 1 Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Activin Receptor Type 1 Revenue Market Share by Company (2021-2026) Table 32. Global Activin Receptor Type 1 Sales by Company (2021-2026) & (W Units) Table 33. Global Activin Receptor Type 1 Sales Share by Company (2021-2026) Table 34. Global Activin Receptor Type 1 Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Activin Receptor Type 1 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Activin Receptor Type 1 Major Company Production Sites and Headquarters Table 37. Global Activin Receptor Type 1 Company, Product Type & Application Table 38. Global Activin Receptor Type 1 Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Activin Receptor Type 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Activin Receptor Type 1 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Activin Receptor Type 1 Sales by Region (2021-2026) & (W Units) Table 43. Global Activin Receptor Type 1 Sales Market Share in Volume by Region (2021-2026) Table 44. Global Activin Receptor Type 1 Sales by Region (2021-2026) & (US$ Million) Table 45. Global Activin Receptor Type 1 Sales Market Share in Value by Region (2021-2026) Table 46. Global Activin Receptor Type 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Activin Receptor Type 1 Sales by Region (2027-2032) & (W Units) Table 48. Global Activin Receptor Type 1 Sales Market Share in Volume by Region (2027-2032) Table 49. Global Activin Receptor Type 1 Sales by Region (2027-2032) & (US$ Million) Table 50. Global Activin Receptor Type 1 Sales Market Share in Value by Region (2027-2032) Table 51. Global Activin Receptor Type 1 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Activin Receptor Type 1 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Activin Receptor Type 1 Sales by Application (2021-2026) & (W Units) Table 54. Global Activin Receptor Type 1 Sales Market Share in Volume by Application (2021-2026) Table 55. Global Activin Receptor Type 1 Sales by Application (2021-2026) & (US$ Million) Table 56. Global Activin Receptor Type 1 Sales Market Share in Value by Application (2021-2026) Table 57. Global Activin Receptor Type 1 Price by Application (2021-2026) & (US$/Unit) Table 58. Global Activin Receptor Type 1 Sales by Application (2027-2032) & (W Units) Table 59. Global Activin Receptor Type 1 Sales Market Share in Volume by Application (2027-2032) Table 60. Global Activin Receptor Type 1 Sales by Application (2027-2032) & (US$ Million) Table 61. Global Activin Receptor Type 1 Sales Market Share in Value by Application (2027-2032) Table 62. Global Activin Receptor Type 1 Price by Application (2027-2032) & (US$/Unit) Table 63. North America Activin Receptor Type 1 Sales by Application (2021-2026) & (W Units) Table 64. North America Activin Receptor Type 1 Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Activin Receptor Type 1 Sales by Application (2021-2026) & (W Units) Table 66. Europe Activin Receptor Type 1 Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Activin Receptor Type 1 Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Activin Receptor Type 1 Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Activin Receptor Type 1 Sales by Application (2021-2026) & (W Units) Table 70. Latin America Activin Receptor Type 1 Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Activin Receptor Type 1 Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Activin Receptor Type 1 Sales by Application (2021-2026) & (US$ Million) Table 73. Tolero Pharmaceuticals Inc Company Information Table 74. Tolero Pharmaceuticals Inc Business Overview Table 75. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product Portfolio Table 77. Tolero Pharmaceuticals Inc Recent Development Table 78. Oncodesign SA Company Information Table 79. Oncodesign SA Business Overview Table 80. Oncodesign SA Activin Receptor Type 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Oncodesign SA Activin Receptor Type 1 Product Portfolio Table 82. Oncodesign SA Recent Development Table 83. La Jolla Pharmaceutical Company Company Information Table 84. La Jolla Pharmaceutical Company Business Overview Table 85. La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. La Jolla Pharmaceutical Company Activin Receptor Type 1 Product Portfolio Table 87. La Jolla Pharmaceutical Company Recent Development Table 88. Daiichi Sankyo Company Ltd Company Information Table 89. Daiichi Sankyo Company Ltd Business Overview Table 90. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product Portfolio Table 92. Daiichi Sankyo Company Ltd Recent Development Table 93. Blueprint Medicines Corp Company Information Table 94. Blueprint Medicines Corp Business Overview Table 95. Blueprint Medicines Corp Activin Receptor Type 1 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Blueprint Medicines Corp Activin Receptor Type 1 Product Portfolio Table 97. Blueprint Medicines Corp Recent Development Table 98. North America Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 99. North America Activin Receptor Type 1 Sales by Country (2021-2026) & (W Units) Table 100. North America Activin Receptor Type 1 Sales Market Share by Country (2021-2026) Table 101. North America Activin Receptor Type 1 Sales Forecast by Country (2027-2032) & (W Units) Table 102. North America Activin Receptor Type 1 Sales Market Share Forecast by Country (2027-2032) Table 103. North America Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Activin Receptor Type 1 Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Activin Receptor Type 1 Market Share by Country (2021-2026) Table 106. North America Activin Receptor Type 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Activin Receptor Type 1 Market Share Forecast by Country (2027-2032) Table 108. Europe Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 109. Europe Activin Receptor Type 1 Sales by Country (2021-2026) & (W Units) Table 110. Europe Activin Receptor Type 1 Sales Market Share by Country (2021-2026) Table 111. Europe Activin Receptor Type 1 Sales Forecast by Country (2027-2032) & (W Units) Table 112. Europe Activin Receptor Type 1 Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Activin Receptor Type 1 Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Activin Receptor Type 1 Market Share by Country (2021-2026) Table 116. Europe Activin Receptor Type 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Activin Receptor Type 1 Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Activin Receptor Type 1 Sales by Country (2021-2026) & (W Units) Table 120. Asia-Pacific Activin Receptor Type 1 Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Activin Receptor Type 1 Sales Forecast by Country (2027-2032) & (W Units) Table 122. Asia-Pacific Activin Receptor Type 1 Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Activin Receptor Type 1 Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Activin Receptor Type 1 Market Share by Country (2021-2026) Table 126. Asia-Pacific Activin Receptor Type 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Activin Receptor Type 1 Market Share Forecast by Country (2027-2032) Table 128. Latin America Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 129. Latin America Activin Receptor Type 1 Sales by Country (2021-2026) & (W Units) Table 130. Latin America Activin Receptor Type 1 Sales Market Share by Country (2021-2026) Table 131. Latin America Activin Receptor Type 1 Sales Forecast by Country (2027-2032) & (W Units) Table 132. Latin America Activin Receptor Type 1 Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Activin Receptor Type 1 Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Activin Receptor Type 1 Market Share by Country (2021-2026) Table 136. Latin America Activin Receptor Type 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Activin Receptor Type 1 Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Activin Receptor Type 1 Sales by Country (2021-2026) & (W Units) Table 140. Middle East and Africa Activin Receptor Type 1 Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Activin Receptor Type 1 Sales Forecast by Country (2027-2032) & (W Units) Table 142. Middle East and Africa Activin Receptor Type 1 Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Activin Receptor Type 1 Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Activin Receptor Type 1 Market Share by Country (2021-2026) Table 146. Middle East and Africa Activin Receptor Type 1 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Activin Receptor Type 1 Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Activin Receptor Type 1 Distributors List Table 151. Activin Receptor Type 1 Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Activin Receptor Type 1 Image Figure 2. Global Activin Receptor Type 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Activin Receptor Type 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Activin Receptor Type 1 Sales (2021-2032) & (W Units) Figure 5. LJPC-6417 Image Figure 6. Global LJPC-6417 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Dipyridamole Image Figure 8. Global Dipyridamole Sales YoY Growth (2021-2032) & (W Units) Figure 9. TP-0184 Image Figure 10. Global TP-0184 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Activin Receptor Type 1 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Activin Receptor Type 1 Market Share by Type 2025 VS 2032 Figure 15. North America Activin Receptor Type 1 Sales Market Share in Volume by Type in 2025 Figure 16. North America Activin Receptor Type 1 Sales Market Share in Value by Type in 2025 Figure 17. Europe Activin Receptor Type 1 Sales Market Share in Volume by Type in 2025 Figure 18. Europe Activin Receptor Type 1 Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Activin Receptor Type 1 Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Activin Receptor Type 1 Sales Market Share in Value by Type in 2025 Figure 21. Latin America Activin Receptor Type 1 Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Activin Receptor Type 1 Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Activin Receptor Type 1 Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Activin Receptor Type 1 Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Activin Receptor Type 1 Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Alport Syndrome Image Figure 28. Global Alport Syndrome Sales YoY Growth (2021-2032) & (W Units) Figure 29. Kidney Fibrosis Image Figure 30. Global Kidney Fibrosis Sales YoY Growth (2021-2032) & (W Units) Figure 31. Chronic Kidney Disease Image Figure 32. Global Chronic Kidney Disease Sales YoY Growth (2021-2032) & (W Units) Figure 33. Obesity Image Figure 34. Global Obesity Sales YoY Growth (2021-2032) & (W Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 37. Global Activin Receptor Type 1 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Activin Receptor Type 1 Market Share by Application 2025 VS 2032 Figure 39. North America Activin Receptor Type 1 Sales Market Share in Volume by Application in 2025 Figure 40. North America Activin Receptor Type 1 Sales Market Share in Value by Application in 2025 Figure 41. Europe Activin Receptor Type 1 Sales Market Share in Volume by Application in 2025 Figure 42. Europe Activin Receptor Type 1 Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Activin Receptor Type 1 Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Activin Receptor Type 1 Sales Market Share in Value by Application in 2025 Figure 45. Latin America Activin Receptor Type 1 Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Activin Receptor Type 1 Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Activin Receptor Type 1 Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Activin Receptor Type 1 Sales Market Share in Value by Application in 2025 Figure 49. North America Activin Receptor Type 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. North America Activin Receptor Type 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Activin Receptor Type 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Activin Receptor Type 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Europe Activin Receptor Type 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Activin Receptor Type 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Activin Receptor Type 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Asia-Pacific Activin Receptor Type 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Activin Receptor Type 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Activin Receptor Type 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 62. Latin America Activin Receptor Type 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Activin Receptor Type 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Activin Receptor Type 1 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 66. Middle East and Africa Activin Receptor Type 1 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Activin Receptor Type 1 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Activin Receptor Type 1 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Activin Receptor Type 1 Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Activin Receptor Type 1 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • LJPC-6417
  • Dipyridamole
  • TP-0184
  • Others
Applications
  • Alport Syndrome
  • Kidney Fibrosis
  • Chronic Kidney Disease
  • Obesity
  • Others
Companies covered
  • Tolero Pharmaceuticals Inc
  • Oncodesign SA
  • La Jolla Pharmaceutical Company
  • Daiichi Sankyo Company Ltd
  • Blueprint Medicines Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Activin Receptor Type 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Activin Receptor Type 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Activin Receptor Type 1 Market by Type
  6. 1.3.1 LJPC-6417
  7. 1.3.2 Dipyridamole
  8. 1.3.3 TP-0184
  9. 1.3.4 Others
  10. 1.4 Global Activin Receptor Type 1 Market Size by Type
  11. 1.4.1 Global Activin Receptor Type 1 Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Activin Receptor Type 1 Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Activin Receptor Type 1 Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Activin Receptor Type 1 Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Activin Receptor Type 1 Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Activin Receptor Type 1 Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Activin Receptor Type 1 Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Activin Receptor Type 1 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Activin Receptor Type 1 Industry Trends
  2. 2.2 Activin Receptor Type 1 Industry Drivers
  3. 2.3 Activin Receptor Type 1 Industry Opportunities and Challenges
  4. 2.4 Activin Receptor Type 1 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Activin Receptor Type 1 Revenue (2021-2026)
  2. 3.2 Global Top Players by Activin Receptor Type 1 Sales (2021-2026)
  3. 3.3 Global Top Players by Activin Receptor Type 1 Price (2021-2026)
  4. 3.4 Global Activin Receptor Type 1 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Activin Receptor Type 1 Major Company Production Sites & Headquarters
  6. 3.6 Global Activin Receptor Type 1 Company, Product Type & Application
  7. 3.7 Global Activin Receptor Type 1 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Activin Receptor Type 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Activin Receptor Type 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Activin Receptor Type 1 Tier 1, Tier 2, and Tier 3
4 Activin Receptor Type 1 Regional Status and Outlook
  1. 4.1 Global Activin Receptor Type 1 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Activin Receptor Type 1 Historic Market Size by Region
  3. 4.2.1 Global Activin Receptor Type 1 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Activin Receptor Type 1 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Activin Receptor Type 1 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Activin Receptor Type 1 Forecasted Market Size by Region
  7. 4.3.1 Global Activin Receptor Type 1 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Activin Receptor Type 1 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Activin Receptor Type 1 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Activin Receptor Type 1 by Application
  1. 5.1 Activin Receptor Type 1 Market by Application
  2. 5.1.1 Alport Syndrome
  3. 5.1.2 Kidney Fibrosis
  4. 5.1.3 Chronic Kidney Disease
  5. 5.1.4 Obesity
  6. 5.1.5 Others
  7. 5.2 Global Activin Receptor Type 1 Market Size by Application
  8. 5.2.1 Global Activin Receptor Type 1 Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Activin Receptor Type 1 Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Activin Receptor Type 1 Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Activin Receptor Type 1 Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Activin Receptor Type 1 Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Activin Receptor Type 1 Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Activin Receptor Type 1 Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Activin Receptor Type 1 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Tolero Pharmaceuticals Inc
  2. 6.1.1 Tolero Pharmaceuticals Inc Company Information
  3. 6.1.2 Tolero Pharmaceuticals Inc Business Overview
  4. 6.1.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product Portfolio
  6. 6.1.5 Tolero Pharmaceuticals Inc Recent Developments
  7. 6.2 Oncodesign SA
  8. 6.2.1 Oncodesign SA Company Information
  9. 6.2.2 Oncodesign SA Business Overview
  10. 6.2.3 Oncodesign SA Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Oncodesign SA Activin Receptor Type 1 Product Portfolio
  12. 6.2.5 Oncodesign SA Recent Developments
  13. 6.3 La Jolla Pharmaceutical Company
  14. 6.3.1 La Jolla Pharmaceutical Company Company Information
  15. 6.3.2 La Jolla Pharmaceutical Company Business Overview
  16. 6.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product Portfolio
  18. 6.3.5 La Jolla Pharmaceutical Company Recent Developments
  19. 6.4 Daiichi Sankyo Company Ltd
  20. 6.4.1 Daiichi Sankyo Company Ltd Company Information
  21. 6.4.2 Daiichi Sankyo Company Ltd Business Overview
  22. 6.4.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product Portfolio
  24. 6.4.5 Daiichi Sankyo Company Ltd Recent Developments
  25. 6.5 Blueprint Medicines Corp
  26. 6.5.1 Blueprint Medicines Corp Company Information
  27. 6.5.2 Blueprint Medicines Corp Business Overview
  28. 6.5.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Blueprint Medicines Corp Activin Receptor Type 1 Product Portfolio
  30. 6.5.5 Blueprint Medicines Corp Recent Developments
7 North America by Country
  1. 7.1 North America Activin Receptor Type 1 Sales by Country
  2. 7.1.1 North America Activin Receptor Type 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Activin Receptor Type 1 Sales by Country (2021-2026)
  4. 7.1.3 North America Activin Receptor Type 1 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Activin Receptor Type 1 Market Size by Country
  6. 7.2.1 North America Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Activin Receptor Type 1 Market Size by Country (2021-2026)
  8. 7.2.3 North America Activin Receptor Type 1 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Activin Receptor Type 1 Sales by Country
  2. 8.1.1 Europe Activin Receptor Type 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Activin Receptor Type 1 Sales by Country (2021-2026)
  4. 8.1.3 Europe Activin Receptor Type 1 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Activin Receptor Type 1 Market Size by Country
  6. 8.2.1 Europe Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Activin Receptor Type 1 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Activin Receptor Type 1 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Activin Receptor Type 1 Sales by Country
  2. 9.1.1 Asia-Pacific Activin Receptor Type 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Activin Receptor Type 1 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Activin Receptor Type 1 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Activin Receptor Type 1 Market Size by Country
  6. 9.2.1 Asia-Pacific Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Activin Receptor Type 1 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Activin Receptor Type 1 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Activin Receptor Type 1 Sales by Country
  2. 10.1.1 South America Activin Receptor Type 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Activin Receptor Type 1 Sales by Country (2021-2026)
  4. 10.1.3 South America Activin Receptor Type 1 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Activin Receptor Type 1 Market Size by Country
  6. 10.2.1 South America Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Activin Receptor Type 1 Market Size by Country (2021-2026)
  8. 10.2.3 South America Activin Receptor Type 1 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Activin Receptor Type 1 Sales by Country
  2. 11.1.1 Middle East and Africa Activin Receptor Type 1 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Activin Receptor Type 1 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Activin Receptor Type 1 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Activin Receptor Type 1 Market Size by Country
  6. 11.2.1 Middle East and Africa Activin Receptor Type 1 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Activin Receptor Type 1 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Activin Receptor Type 1 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Activin Receptor Type 1 Value Chain Analysis
  2. 12.1.1 Activin Receptor Type 1 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Activin Receptor Type 1 Production Mode & Process
  7. 12.2 Activin Receptor Type 1 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Activin Receptor Type 1 Distributors
  10. 12.2.3 Activin Receptor Type 1 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst